By inhibiting apoptotic signalling, PGAM5 (PGAM family member 5) has been shown to be a poor prognostic factor for patients with hepatocellular carcinoma,23 which is consistent with our findings. This evidence concerns the gene PGAM5 and hepatocellular carcinoma.